Latest news for Vita 34 (OTC:VTIAF) Stock

Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34.

VITA 34 AG NAMEN-AKT by Vita 34 International AG

Comments

Vita 34

News

Latest news for Vita 34 (OTC:VTIAF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga